Profil
Mr. Robert McRae is a President & Chief Operating Officer at Sidewinder Therapeutics, Inc. Mr. McRae was previously employed as a Chief Operating Officer by Palisade Bio, Inc., a Vice President-Operations & Strategic Alliances by Viracta Subsidiary, Inc., and a Vice President-Operations & Strategic Alliances by Viracta Therapeutics, Inc. He received his undergraduate degree from Wright State University (Ohio).
Aktive Positionen von Robert McRae
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Robert McRae
| Unternehmen | Position | Ende |
|---|---|---|
| PALISADE BIO, INC. | Geschäftsführer | 01.05.2023 |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Geschäftsführer | - |
Ausbildung von Robert McRae
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Wright State University (Ohio)
Wright State University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
















